pelvic fracture
Conditions
Interventions
Experimental group:Pelvic fracture patients with closed reduction and internal fixation by the need to random experimental apparatus
Control group:Pelvic fracture patients with closed reduction and internal fixation by traditional operation method
Sponsors
Beijing Jishuitan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18-80 years old, gender is not limited; 2. Closed unstable pelvic ring injury requiring reduction (Tile type B or C); 3. The expected surgical treatment time is within 2 weeks from the fracture occurrence time; 4. The subjects fully understand the benefits and risks of this trial, are willing to participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Serious open injury or rupture of abdominal pelvic cavity and organs with wound contamination; 2. Subjects with bilateral fractures and significant displacement, so that it is impossible to use the orthopedic surgical navigation system to complete the surgical planning; 3. The vital signs are not stable enough, and may not be able to tolerate anesthesia or surgery after evaluation by the investigator; 4. The local skin condition is not good, or the site where the implant is expected to be inserted or the soft tissue around it is infected; 5. Systemic diseases, such as severe bleeding disorders, severe heart disease and severe respiratory diseases; 6. Pathological fracture (such as primary or metastatic tumor) or revision surgery (such as malunion, nonunion or infection); 7. The patient has contraindications to anesthesia and surgery; 8. Patients are currently receiving chemotherapy or radiotherapy, systemic application of corticosteroids or growth factors; 9. The patient has problems such as drug abuse, schizophrenia, dementia, etc., and the researcher judges that the experiment cannot be completed according to the research plan; 10. Family planning, lactating and pregnant women throughout the clinical research period; 11. Patients who have participated in or are currently participating in clinical trials of other drugs or medical devices within the past month; 12. The investigator believes that it is not suitable to participate in this clinical trial due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Excellent and good rate of pelvic closed reduction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction accuracy;Number of fluoroscopy;Functional score;Fracture healing rate;Evaluation of the functional, stability and convenience of the whole machine;Evaluation of the use of matching tools; | — |
Countries
China
Contacts
Public ContactWu Xinbao
Beijing Jishuitan Hospital
Outcome results
None listed